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At a recent Global Health conference, the plenary speaker, Melissa Leach, made the 
following observation: “If the Ebola epidemic of 2014-15 has marked a defining moment for 
global health, highlighting inescapably the threats unleashed by dynamic bio-socialities in 
interconnected and unequal worlds, it has also been a defining moment for anthropology’s 
position and contribution”. For Leach, the ‘Ebola moment’ calls for scholars across the 
social sciences and humanities to cut into the dominant paradigm of biomedicine and health 
science that currently undergirds global health.  
 While social scientists continue to query the concrete nature – or very existence of – 
global health (Brown et al. 2010, Fassin 2012), the ever-multiplying conferences, journal 
titles, degree programmes, experts, policies and so on, testify to its persistence as an 
enduring and dominant framework through which the everyday realities and vitality of world 
populations are known and intervened upon. Social scientists and humanities scholars have 
been at pains to critique the methods, epistemologies and effects of global health (Biehl and 
Petryna 2013, Mold and Reubi 2013, Petryna 2009), and yet questions persist about the best 
ways to engage with its intricate machinery.  
The authors illustrate the complexities and tensions inherent in global health 
programmes and interventions, staying empirically close to practitioners and researchers 
working across intricate webs of internationally networked institutions, clinics and research 
centres. Crane’s book Scrambling for Africa attends to the architecture of global health and its 
administrative scaffolding. Crane refers to global health as a juggernaut (2013, p. 149), 
alluding to what often appears to be its unstoppable and irresistible force. Unstoppable 
because global health absorbs an ever-growing number of networked institutions, 
programmes, experts, and policies that extend its global reach and influence. Irresistible, 
because it attracts growing numbers of practitioners that are driven by humanitarian 
concerns, but arguably also by the availability of auspicious funding opportunities. And yet, 
the juggernaut metaphor implies that global health can be destructive; as both monographs 
under review caution, global health also erases, crushes, brushes aside forms of knowledge 
and ways of living that do not readily comply with its prevailing imperative for objective, 
measurable, and cost-effective solutions, and its overall mission to improve the health and 
wellbeing of world populations. 
1 
Crane specifically draws our attention to the span of international collaborative 
networks and their implicit politics of exclusion. But exclusion is also the key concern of 
Michael and Rosengarten’s Innovation and Biomedicine, which analyses efforts to standardise 
biomedical tests and treatments according to internationally sanctioned ‘gold standard’ 
criteria, and the consequent tensions this creates for practitioners on the ground. While 
global health often takes on the appearance of an unstoppable ‘juggernaut’ (Crane, p.149), 
both books expose the tensions and contradictions involved in the spread of global scientific 
networks and setting of gold standards, and thus carve out new and innovative social science 
critiques.   
 
Global scientific networks and the new scramble for Africa 
The central thesis of Crane’s book is that the growth of global health programmes 
emanating mainly from the Global North “both generates and relies upon” (p. 7) conditions 
of poverty and disease in the Global South. Crane’s study cuts into conceptual debates about 
what counts as global health by arguing that while talk of equal partnerships is prevalent 
amongst practitioners (Koplan et al 2009), there is a lacuna in our understanding of how 
projects and the entailed collaborative relationships actually take shape. In addressing this 
gap, Crane focuses her study on HIV and AIDS research in Uganda. Her primary case study 
reports on the expansion of the Immune Wellness Clinic (which is a pseudonym) in 
Mbarara, southeast Uganda, which over ten years went from a single shipping container to a 
functioning medical laboratory subsumed within a larger donor-funded research 
infrastructure.  
The title of the book is itself telling, referring to the Berlin Conference in the late 
nineteenth century when European countries initiated a ‘scramble for Africa’ in which they 
competed for shares in the continent’s land and resources. The beginning chapters set-up 
the premise that global health represents a somewhat similar scramble, but it is bodies and 
their biovalue that are framed as having untold resource to universities in the Global North, 
and in effect in securing the health and wellbeing of global populations. Indeed, Crane uses 
the rather unfortunate language of Africa as “fodder” (p. 7) for global health research, albeit 
in later more ethnographic chapters she offers a more nuanced perspective by chronicling 
the collaborative networks and knowledge flows that are part of global health in the making.  
The current ‘scramble for Africa’ can be seen in the global fight against HIV/AIDS, 
which Crane argues has been progressively shaped by the conjoined efforts of private 
philanthropic capital and publicly funded research agendas. The initial denial of 
antiretrovirals to African populations - despite escalating HIV infection rates - has given way 
to large-scale internationally funded health intervention programs guided by humanitarian 
concerns. At the same time, global health research increasingly relies on previously 
neglected, and thus ‘treatment naive’, African bodies in order to test the efficacy of newer 
drugs. What Crane concludes is that it has become difficult to tear apart basic research from 
targeted interventions; in global health they are often intertwined.  
There is the scent in these initial chapters of Tilley’s Africa as Living Laboratory (2011) 
but written in a contemporary moment and concerned more with the biomedicalisation of 
poorer populations in the epistemological regimes of the Global North. However, like Tilley, 
Crane seeks to admonish any notion that global health is a well-oiled machine operating 
effortlessly to enroll bodies, identities and communities in its processes. Instead, she skillfully 
shows how global health progresses and indeed emerges through continual struggle and 
chafing at the level of individual programmes and the collaborative networks they generate. 
She makes two important observations that bring together her main theoretical influences of 
medical anthropology and science and technology studies (STS). One observation concerns 
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the setting up of laboratories and the other, the recent expansion of global health degree 
programmes in mainly Northern Universities. 
Long the mainstay of STS, the laboratory takes on different qualities in an African 
context serving as a highly visible sign of philanthropy and as such an expression of 
inequality. While laboratories and their technological kits are often donated, they usher in 
new epistemological orders that mute other ways of doing biomedical research. Crane 
approaches the laboratory as a boundary object that binds research and health interventions, 
while also contributing to a more divisive separation between international circuits of 
scientific capital and the geographically anchored status of Ugandan researchers, doctors and 
patients. As Crane herself states “the geography of laboratories is the geography of scientific 
networks” (p. 105). By this, she means that while laboratories represent the arrival of global 
health programmes and carry much of its promissory capital, they form nodes in the global 
transfer of biological data.   
Staying true to STS, Crane argues that laboratories are sites of extraction and 
translation, and it is through these practices that historical inequalities between the Global 
North and South are reproduced. Labs are ultimately invested in enabling the mobility of 
some epistemologies, objects and people, which necessarily anchors others in place, 
contributing to what Malkki argues is a ‘sedentarist metaphysics’ (cited in Crane 2013, p. 
148). In the context of the Wellness Clinic, Crane found disgruntlement amongst Ugandan 
researchers and doctors who complained that they were readily positioned as recipients of 
donor funds rather than as equal partners who participate in and enjoy the rewards of the 
scientific networks they help to sustain. 
The second important observation she makes is about the growth of degree 
programmes, research centres and institutes dedicated to global health. The political 
economy of higher education – in the form of increased commercialisation, impact agendas, 
research audit and managerial cultures - looms in the background of Crane’s study and there 
is work to be done tying economic changes in higher education to the emergence of global 
health. Crane might well be correct in arguing that from inside the halls of rich, powerful 
universities a new ‘scramble for Africa’ is underway.  
As a faculty member at the University of Washington, Crane finds herself in the 
business of global health and she appears in these final chapters to be grappling with its 
paradoxical dimensions. In locating herself critically in response the growing demand for 
global health degrees and research projects, she reaches out beyond the academy to policy 
makers, practitioners and university managers with the take home message that “...if global 
health wishes to truly make strides towards its ethic of equitable partnership, the field must 
make a more genuine effort to grapple with the unequal terrain on which it operates and 
which ultimately serves as its condition of possibility” (p. 171). 
 
Clinical trials and the struggle for global standards 
Mike Michael and Marsha Rosengarten’s book Innovation and Biomedicine (2013) also 
focuses on off-shore HIV RCTs (Randomised Controlled Trials) as instantiations of 
globalising biomedicine. And, like Crane, Michael and Rosengarten show how biomedicine is 
interwoven with asymmetries in wealth, health and medical infrastructure. On the one hand, 
these are key drivers of the globalisation of biomedicine, providing not only the targets for 
new HIV interventions but also the (treatment-naïve) bodies for new HIV research. But on 
the other hand, biomedicine struggles to address divergences in its continuous strive for 
universal scientific methods, standardised regulatory protocols and one-size-fits all remedies. 
It is this quest for uniform solutions in biomedical research and its adverse consequences 
that are at the center of Michael and Rosengarten’s analysis, leading them to speculate on 
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how biomedical innovations might be imagined otherwise to engender more ethical and 
effective interventions. 
Michael and Rosengarten focus their study on HIV pre-exposure prophylaxis 
(PrEP). Based on a 2-drug combination (tenofovir/emtricitabine) already routinely used as 
part of drug regimen to treat HIV infection, PrEP was approved by the US Food and Drug 
Administration (FDA) in 2012 for the prevention of HIV infection in specific HIV-negative 
but at-risk groups. FDA approval and PrEP’s inclusion in US federal clinical practice 
guidelines rested on the evidence from a number of clinical trials1, many of which were 
conducted outside the US. Michael and Rosengarten use the example of PrEP to explore 
how biomedical intervention are ‘event-uated’ across various settings.   
‘Eventuation’ is the central conceptual device developed throughout Biomedicine and 
Innovation. Informed by the concept of the event as articulated by Whitehead and further 
conceptualised by Deleuze, Stengers, and Fraser (see e.g. Fraser 2009), Michael and 
Rosengarten use eventuation to describe the situated and relational coming into being of 
entities such as PrEP and challenge reductionist accounts of biomedical innovations. The 
concept of eventuation is articulated through two complementary chapters that offer 
contrasting descriptions of PrEP RCTs as either closed or open events and offer a 
provocative methodological contribution to ongoing social science debates concerning the 
‘becoming’ of entities. 
 In the first of these twinned chapters, ‘The gold standard’, Michael and Rosengarten 
illustrate how biomedicine treats both RCTs and PrEP as distinct and singular entities that 
unproblematically circulate the globe. RCTs are seen as the gold-standard methodology of 
biomedical knowledge production that validate PrEP as a universally-applicable innovation 
to prevent HIV infection. However, Michael and Rosengarten argue that ‘gold-standardness’ 
can never be realised in specific trials or in a specific pill. Instead, it only exists as an abstract 
external criteria that solicits, among other things, objectivity and comparability. Yet, it is by 
being oriented towards this ideal that specific RCTs and PrEP are eventuated as singular 
entities.  
The specific processes leading to this singularisation of RCTs and PrEP include 
quantification and bifurcation. According to Michael and Rosengarten, quantification 
techniques retain only those aspects of RCTs and PrEP that can be measured and compared 
across different settings, protocols and bodies. Bifurcation occurs when everything deemed 
disruptive to the attainment of ‘gold standardness’ is stripped away, including what could be 
understood as the particular social contexts in which both trials and pill-taking take place. 
Michael and Rosengarten point to the distinction between the ‘efficacy’ and ‘effectiveness’ of 
PrEP as indicative of the bifurcation between ‘biomedical’ and ‘social’ (p.82). Efficacy is 
determined by evidence of the ‘true’ workings of a drug in standardised research settings and 
‘controlled’ patient groups. In contrast, effectiveness is demonstrated by showing that drugs 
work in ‘real-life’ patients and diverse locales – which are thus treated as providing merely 
supplementary knowledge of already scientifically-validated drugs (see p. 5).  
When efficacy is sought as the ‘external criterion’ against which PrEP is evaluated in 
RCTs, Michael and Rosengarten argue that PrEP is then eventuated as a uniform and 
abstracted entity that can fulfil these criteria – or in the words of Brives (2013: 412) “the 
clinical trial as a scientific experiment generates both the results and the objects required to obtain these 
results”. If attaining gold-standardness eventuates PrEP as the solution to problems of 
comparability and transferability, then can it prevent HIV infection in situated and often 
‘messy’ settings? While Michael and Rosengarten arrive at this question through their critique 
                                            
1 See 
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm312210.htm  
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of quantification and bifurcation, it is in the successive chapter that they develop a far more 
radical reimagining of how PrEP could be eventuated otherwise if we modified our 
conception of scientific experiments by considering their multiple and relational dimensions.  
Here they contrast eventuations of RCTs and PrEP as singular, quantitative and 
standardised with an examination of RCTs and PrEP as multiple, qualitative, and ‘open’. A 
key conceptual tool they propose is the notion of ‘anti-attractor’; at the same time that the 
strive for gold-standardness constrains scientific experiments, it also opens up new 
possibilities as it “orients the RCT event towards alternative prospects, precipitating 
‘counter-reactions’ and the likely actualization of unanticipated elements of the RCT PrEP 
event” (p.107). 
Revisiting their empirical material, Michael and Rosengarten describe how experts 
struggle to achieve the abstracted standards of trial design and deliverables. Similar to Crane, 
Michael and Rosengarten describe how the seamless appearance of gold standardness 
conceals the tensions experienced by researchers and clinicians who manage trials on the 
ground. They refer to these as situated and ‘qualifying’ challenges: for example, trial 
participants might adhere less to treatment regimen than expected, taking PrEP might 
change participants’ sex practices or might affect gender relations, lower-than-expected 
adherence might lead to virus resistance. As experts try to obtain standardised trial results in 
defiance of these challenges, both RCTs and PrEP become open to contestation and 
adaptation. In other words, attempts to standardise become ‘generative’ of new and 
unexpected problems that need to be worked out in situ (p.127). As a result, rather than 
being understood as singular and sealed-off entities, RCTs are shown to be multiple and 
relational in that they ‘emerge-with’ the things that go into their eventuation. 
By playfully teasing out the relational ontologies of RCTs and PrEP, Michael and 
Rosengarten ultimately invite us to radically reconsider the role of scientific experiments in 
HIV drug research, and even biomedicine more broadly. Instead of viewing PrEP RCTs as 
gold-standard solutions to pre-defined problems (p.17), they suggest reimagining them as 
situated and open experimental events that allow working through complexities and new 
problems as they arise. What exactly such a reimagined RCT might look like, or how it might 
be successfully incorporated into current biomedical practices, is left to the reader’s 
speculation. Yet, the real strength of Michael and Rosengarten’s book is their teasing out in 
these two central chapters of the performative character of knowledge practices. 
 
From under the wheel of the juggernaut: new approaches in social science critique  
Both books attend to the unexpected dimensions of global health, critiquing not only 
the recapitulation of long-standing power relationships, but also the veneer of global health 
as operating smoothly and seamlessly. In their focus on two key building blocks – global 
scientific networks and research standards – the authors highlight how the appearance of a 
smooth veneer belies the highly contextualized tensions through which global health 
programmes and initiatives operate. While this highlights the fragile architecture of the self-
professed field of global health, both books seem to go a step further by suggesting that any 
allusion to a ‘global health’ is ultimately a smokescreen that conceals the (neo-)imperial 
tendencies that continue to steer the political economy of knowledge production. 
The authors deploy social science to bring empirical insight to the messy and tension 
ridden ways in which global health gets done in practice, but they also question why the 
complexity of these practices does not figure in the political deliberations of dominant 
multinational scientific, health and philanthropic organisations as anything other than 
external obstacles to be erased and overcome. Why does complexity, multiplicity and tension 
not figure more creatively in the socio-technical imaginations of global health? And 
5 
moreover, what are the ethics of this exclusion? This brings us back to the question raised by 
Leach concerning the role and contributions of social science in global health.  
The international response to the Ebola epidemic actively sought to include social 
scientists, especially anthropologists, in implementing interventionist and containment 
measures. For many, this involvement signalled an acknowledgement of the value of applied 
social science to the work of organisations such as the World Health Organisation. For 
others, the excitement of being invited to the big league of policy-interventions has given 
way to an ‘Ebola-induced hangover’ (Menzel and Schroven, 2016), brought on by increasing 
frustrations at being enrolled as service providers to help smooth over the implementation 
of pre-determined ‘good’ interventions and projects (Krause, 2014; Menzel and Schroven, 
2016).  
Indeed, global health often appears as a ‘juggernaut’ (Crane, p.149) whose composite 
institutions and corporations, biomedical epistemologies and targeted research-interventions 
are constitutive of new calculable spaces at the expense of other ways of being and knowing. 
While these calculable spaces engender standardised and universalised regimes of knowledge, 
they also form part of a self-referential system that serves to justify the perpetual need for 
global health. Both books cut into these calculable spaces by making visible the tensions, 
multiplicity and relationality of any knowledge-making activity. These qualities are often 
treated as incidental or arbitrary to the overall aims of global health, rather than part of its 
fabric. By bringing our attention to these tacit and often invisible aspects, the authors pose 
more urgent ethical questions about how global health ought to be done, by whom and for 
whom.  
In Crane’s parting words to policy communities she asks that they acknowledge the 
dialectics of global health in reproducing the world they seek to remedy. In a similar vein, 
Michael and Rosengarten craft an innovative critique that serves to augment the relevant 
contributions of social science in questioning the problems that we want ‘global’ and 
‘evidence-based’ health interventions to address. As such, both books encourage 
contributions from social science that continue to interrogate the world-making potential of 
global health. The authors demonstrate that this is the real strength of social science - that in 
its embrace of difference and heterogeneity it can reimagine any onto-epistemological 
enterprise - and when it comes to global health, they also make this their ethical imperative.   
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